This content is from: Research The 2013 All-America Research Team: Pharmaceuticals/Specialty, No. 2: Gregory Gilbert Gregory Gilbert of Bank of America Merrill Lynch holds second place for a fifth straight year. October 08, 2013
This content is from: Portfolio Daily Agenda: Euro Inflation Remains Muted Ahead of ECB Meeting Unemployment and prices fall in Germany; Audi drives Volkswagen quarterly profit; another Chinese flash crash; Jazz proposes Celator buy. By Andrew Barber May 31, 2016
This content is from: Portfolio Hedge Fund Manager Kyle Bass Declares War on Drug Prices Through his Coalition for Affordable Drugs, Bass is challenging pharmaceuticals companies’ patents and shorting their stocks. By Jess Delaney October 22, 2015
This content is from: Premium Wild Ride for Joseph Edelman’s Perceptive Advisors The New York firm’s Perceptive Life Sciences fund was able to significantly cut its losses after several of its stock picks soared during a volatile week. By Stephen Taub June 06, 2016
This content is from: Premium What’s Driving This Perry Alum’s Uncorrelated Returns Technology specialist Cadian Capital is surging this year — without any help from the most popular hedge fund stocks. By Stephen Taub June 19, 2018
This content is from: Portfolio Daily Agenda: Markets Digest Trump Nomination Factoring in the risks of political uncertainty; Phillips Lighting debuts; Valeant enterained buyout offer; China train builder sells equity. By Andrew Barber May 27, 2016
